CervoMed to Participate in the Emerging Growth Conference 66
January 05, 2024 08:00 ET
|
CervoMed Inc.
BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced that...